Optimising pandemic response through vaccination strategies using neural networks
Chang Zhai, Ping Chen, Zhuo Jin, David Pitt

TL;DR
This paper introduces a neural network-based framework for optimizing vaccination strategies during pandemics, balancing health outcomes and economic costs through a data-driven, adaptable decision support tool.
Contribution
It presents a novel economic-epidemiological framework that integrates neural networks to calibrate models and optimize vaccination strategies in real-time.
Findings
Empirically derived vaccination strategies for COVID-19 in Victoria, Australia.
Framework effectively balances disease control and economic expenditure.
Supports continuous policy adjustment based on evolving data.
Abstract
Epidemic risk assessment poses inherent challenges, with traditional approaches often failing to balance health outcomes and economic constraints. This paper presents a data-driven decision support tool that models epidemiological dynamics and optimises vaccination strategies to control disease spread whilst minimising economic losses. The proposed economic-epidemiological framework comprises three phases: modelling, optimising, and analysing. First, a stochastic compartmental model captures epidemic dynamics. Second, an optimal control problem is formulated to derive vaccination strategies that minimise pandemic-related expenditure. Given the analytical intractability of epidemiological models, neural networks are employed to calibrate parameters and solve the high-dimensional control problem. The framework is demonstrated using COVID-19 data from Victoria, Australia, empirically…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · Mathematical and Theoretical Epidemiology and Ecology Models · SARS-CoV-2 and COVID-19 Research
